Key result
Explanted Liotta bioprostheses fail predominantly from hemodynamic dysfunction driven by progressive mineralization.
Why the study?
Documentation of failure modes of Liotta porcine bioprostheses is important due to increasing demand and unresolved biodurability issues with new bioprostheses.
What are the failure modes and durability issues of explanted Liotta porcine bioprostheses over time?
Observational (n=56)
What are the failure modes and durability issues of explanted Liotta porcine bioprostheses over time?
Analysis of explanted Liotta porcine bioprostheses highlights that while short-term failures are often thrombotic, long-term durability is primarily limited by mineralization and structural deterioration.
Long-term explant data on porcine bioprostheses inform failure modes; leaves open applicability to contemporary valve designs.
Sixty-two explanted Liotta porcine bioprostheses were examined to review the issues related to their biocompatibility, biofunctionality, and biodurability. These bioprostheses were harvested from 56 patients with implantation times ranging from only a few hours to more than nine years of implantation. There were 10 acute and short-term (< 1 year), 20 midterm (1 < t < 5 years), and 32 long-term (> 5 years) cases. The indications for the reoperations were: hemodynamic (59), thrombosis (10), and endocarditis (3). The major indications varied according to the duration of implantation: blood infiltration, fibrin buildup, thrombosis in the short-term; endocarditis and hemodynamic insufficiency in the midterm; and mineralization and tears causing hemodynamic incompetence in the long term. Mineralization proved to be the main threat to long-term durability for porcine valves. Besides a few short-term failures, these explanted devices slowly degenerated over time and were replaced to prevent congestive heart failure. Documentation of the failure modes of these porcine valves is important since the demand for bioprostheses will increase in the future, in particular for percutaneous devices. Such bioprostheses emphasize a critical biocompatibility issue following implantation because they have the capacity to remain free of thrombus in the absence of anticoagulation. The biofunctionality appears to be adequate in the absence of subsequent pathology with restoration of normal valve function. However, the documentation of such significant long-term biodurability issues raises questions that have been addressed but not fully answered yet with the new generations of bioprostheses.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2008) conducted an observational in Explanted Liotta porcine bioprostheses (n=56). Liotta porcine bioprostheses was evaluated on Indications for reoperation. Explanted Liotta porcine bioprostheses (n=62) were primarily removed due to hemodynamic issues (n=59), thrombosis (n=10), and endocarditis (n=3), with mineralization driving long-term failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: